May 23, 2023 / 12:30PM GMT
Operator
Good day, and thank you for standing by. Welcome to the Wave Life Sciences conference call. (Operator Instructions)
Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your speaker today, Kate Rausch, Vice President of Corporate Affairs and Investor Relations at Wave Life Sciences. Please go ahead.
Kate Rausch - Wave Life Sciences Ltd. - Head of IR
Thank you, operator. This morning, we issued a news release announcing top line data from our FOCUS-C9 clinical trial. A replay of this webcast will be available on the website, www.wavelifesciences.com following today's call.
Before we begin, I'd like to remind you that discussions during this conference call will include forward-looking statements. These statements are subject to a number of risks and uncertainties that could cause our actual results to differ materially from those described in these forward-looking statements. The factors that could cause
WAVE Life Sciences Ltd FOCUS-C9 Clinical Trial Results Conference Call Transcript
May 23, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers